Clinical Trial Update: Preventing Hypertension and Sympathetic Overactivation by Targeting Phosphate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating targeting phosphate to prevent hypertension and sympathetic overactivation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hypertension | Phase 2 | Status: COMPLETED